Dr. Martens (LON:DOCS) Trading 2.1% Higher

Dr. Martens plc (LON:DOCSGet Free Report) shares shot up 2.1% during trading on Wednesday . The stock traded as high as GBX 75.80 ($0.96) and last traded at GBX 73.80 ($0.93). 750,729 shares changed hands during mid-day trading, a decline of 56% from the average session volume of 1,721,581 shares. The stock had previously closed at GBX 72.25 ($0.91).

Dr. Martens Trading Up 2.1 %

The company’s 50-day moving average is GBX 80.89 and its 200-day moving average is GBX 84.98. The company has a debt-to-equity ratio of 143.48, a quick ratio of 1.13 and a current ratio of 2.44. The firm has a market cap of £709.91 million, a price-to-earnings ratio of 738.00, a P/E/G ratio of 0.04 and a beta of 0.01.

Dr. Martens Cuts Dividend

The company also recently announced a dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Thursday, August 29th will be given a dividend of GBX 0.99 ($0.01) per share. The ex-dividend date is Thursday, August 29th. This represents a dividend yield of 1.18%. Dr. Martens’s payout ratio is currently 6,000.00%.

Insider Buying and Selling

In other Dr. Martens news, insider Giles Wilson purchased 73,145 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The stock was acquired at an average cost of GBX 87 ($1.10) per share, with a total value of £63,636.15 ($80,490.96). Insiders bought a total of 73,670 shares of company stock worth $6,408,531 over the last three months. 2.77% of the stock is currently owned by company insiders.

Dr. Martens Company Profile

(Get Free Report)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

See Also

Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.